Spotlight Pathology secures £125,000 in funding from LYVA Labs

Jana Hlistova

Jul 21, 2024

Transcript

Welcome to our #245 weekly newsletter.

“For women taking control of their financial future”

-Jana Hlistova

From The Purse

In this week’s newsletter, we focus on Spotlight Pathology which has raised £125,000 from LYVA Labs based in Liverpool.

***

And you can review the news in brief so you stay on top of global financial, economic and investing trends.

I hope you enjoy this week’s newsletter.

Until next week,

Jana

Spotlight Pathology secures £125,000 in funding from LYVA Labs

Spotlight Pathology has raised £125,000 from its Health and Life Sciences pre-seed fund LYVA Labs, as reported by UK Tech Investment News.

Liverpool-based LYVA Labs is taking the lead in investing in under-served founders and CEOs. And this week the company backed its fourth female-led business.

What problem is Spotlight solving?

Blood cancer diagnosis is currently time-consuming due to the shortage of highly trained pathologists. This leads to delayed diagnosis, treatment and poor patient outcomes.

What is Spotlight’s solution?

Spotlight has developed AI tools to streamline the diagnosis process for blood cancer representing a $15bn global market opportunity.

Spotlight has already secured a £900,000 grant from Innovate UK which has allowed the startup to build up a significant data bank of blood tissue sample.

And they recently recruited Dr Sam Perona as CEO in April, who is joining co-founders Dr Martin Fergie and Prof Richard Byers to lead the business to commercial success.

The CEO of LYVA Labs, Lorna Green is dedicated to tapping the potential of ambitious female entrepreneurs and she chairs Liverpool City Region’s new Female Founder Regional HIGH Growth Board.

And according to Akshay Bhatnagar, Head of Investment, LYVA Labs:

“LYVA Labs is delighted to back Sam, Martin and Richard in their mission to help reduce the number of people dying from blood cancer by providing the technology to allow more rapid diagnosis which will enable earlier treatment for the condition. We look forward to working with the team and seeing the product come to market over the next 12 months.”

Financial news

Nasdaq 100 plunged 2.9% in biggest drop since December as trade angst hit chipmakers and because Trump is not a friend of Big Tech.
Five day outperformance of Russell 2000 vs S&P 500 biggest in US history.
Gold hit a fresh all-time high (ATH) as hopes for Fed rate cuts grow, and some traders ramped up bets on a second Donald Trump presidency.
It seems that investors are buying that Trump wants a weak US Dollar. Speculators have increased their bets against the Greenback.
Speculators have ramped up their bets against long-dated US bonds due to the rising prospects of Trump 2.0.
ECB's Lagarde: what we do in September is wide open. Current interest rates stay the same. Markets are much clearer in this respect. Market participants are pricing in a further interest rate cut with an 80% probability.
UK jobs market cools again as wage growth slows. Interest rate cut hangs in balance after ONS figures show annual pay growth eased to 5.7% in three months to May.
BlackRock is eating the world: world's biggest money manager hits $10.6tn asset record, driven by ETF boost. Total net inflows were $82bn.

Crypto: bitcoin, ethereum, DeFi

Bitcoin tops $67,000, highest price in over a month. The uptick in Bitcoin’s price comes after a punishing stretch. Earlier this month, it dipped as low as $54,000.
Former president Donald Trump’s slated appearance at a Bitcoin conference in Nashville this coming week is an especially bullish factor.
Ethereum and Solana, rose 3.9% and 9.2%, respectively, to $3,500 and $170. Spot Ethereum ETFs are expected to begin trading on Tuesday, 23 July.
JPMorgan analysts say that any rebound in crypto prices from this point is likely to be tactical — temporary and strategic — rather than the start of a lasting upward trend.

Coffee Break? Read This

We’d love to hear from you. Get in touch with Jana via the The Purse website or tweet @jointhepurse and janicka. We do no provide investment advice. Please do your own research or speak to a financial adviser.